Aprea Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $3 | $1 | $118 | $162 |
Gross Profit | 4,382 | -3 | -1,794 | -2,320 |
EBITDA | -2,637 | -2,966 | -3,382 | -4,080 |
EBIT | -2,643 | -2,972 | -3,387 | -4,085 |
Net Income | -2,455 | -2,972 | -3,238 | -3,932 |
Net Change In Cash | 3 | 1 | 118 | 162 |
Free Cash Flow | -3,066 | -3,263 | -3,130 | -3,631 |
Cash | 14,599 | 13,718 | 16,532 | 19,275 |
Basic Shares | 7,687 | 6,372 | 6,083 | 5,993 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $285 | $1,502 | $583 | $0 |
Gross Profit | 264 | -7,860 | 576 | -16,402 |
EBITDA | -13,233 | -14,297 | -14,279 | -37,367 |
EBIT | -13,255 | -14,319 | -14,286 | -37,372 |
Net Income | -12,599 | -12,958 | -14,286 | -112,662 |
Net Change In Cash | 285 | 1,502 | 583 | 0 |
Free Cash Flow | -12,894 | -13,572 | -12,270 | -25,011 |
Cash | 14,599 | 22,849 | 21,606 | 28,786 |
Basic Shares | 6,538 | 5,509 | 3,617 | 82 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.32 |
2025-09-30 | -$0.47 |
2025-06-30 | -$0.53 |
2025-03-31 | -$0.65 |